Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Clobazam vs placebo

Seizure freedom · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 175 participants
Very low

Clobazam vs placebo

Treatment withdrawal · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 197 participants
Very low

Clobazam vs placebo

Withdrawals due to adverse events · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 150 participants
Very low

Clobazam vs placebo

50% reduction in generalised‐onset seizure frequency Not measured · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clobazam vs placebo

50% reduction in focal‐onset seizure frequency Not measured · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Severity of post‐thrombotic syndromeb ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 69 participants
Very low

Intervention not reported

Adverse effects ( · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Patient satisfaction and quality of life · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Compliance rate · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Severity post‐thrombotic syndromeb ( · adults with PTS

The intervention showed no clear difference in severity post‐thrombotic syndromeb ( (low certainty).

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 47 participants
Low

Intervention not reported

Adverse effects ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

Intervention not reported

Patient satisfaction and quality of life ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

Intervention not reported

Compliance rate · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient‐centred outcomes for oral vs IV iron

Death (all causes) · people with CKD

Patient‐centred outcomes for oral showed no clear difference in death (all causes) compared with IV iron (low certainty).

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
RR 1.12 [0.64, 1.94]
11 studies · 1952 participants
Low

Intervention not reported

Ferritin: final or change (µg/L) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
33 studies · 3389 participants
Low

Intervention not reported

TSAT: final or change (%) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
27 studies · 3089 participants
Low

Intervention not reported

HCT (%) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
Very low

Intervention not reported

ESA dose: final or change · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 522 participants
Low

Intervention not reported

eGFR: final or change (mL/min) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1052 participants
Low

Patient‐centred outcomes for oral vs IV iron

Cardiovascular mortality · people with CKD

It is very uncertain whether patient‐centred outcomes for oral changes cardiovascular death compared with IV iron (very low certainty).

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
RR 1.71 [0.41, 7.18]
3 studies · 206 participants
Very low